Jubilant Life Sciences has informed that the Jubilant Employees Welfare Trust (the ‘Trust’) had un-appropriated inventory of 29,65,766 equity shares of the Company of Re 1 each as on October 28, 2014 which was not backed by grant of options. Further, as per the provisions of Jubilant Employees Stock Option Plan 2005 (Plan 2005) read with the Scheme of Amalgamation and Demerger between the Company, Speciality Molecules, Pace Marketing Specialities and Jubilant Industries (JIL), the option holders under Plan 2005 are also entitled to one equity share of Rs 10 each of JIL for every 20 equity shares of Re 1 each of the Company to be issued on exercise of the options. In view of above, the Trust was also holding the un-appropriated inventory of 1,60,130 equity shares of JIL of Rs 10 each on October 28, 2014 which was not backed by grant of options.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: